tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market

Oncolytics Biotech (ONCY) Income Statement

Compare
1,222 Followers

Oncolytics Biotech Income Statement

Last quarter (Q3 2024), Oncolytics Biotech's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Oncolytics Biotech's net income was C$-9.54M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -403.00KC$ -392.00KC$ -452.06KC$ -446.19KC$ -485.57K
Operating Expenses
C$ 33.79MC$ 26.92MC$ 26.23MC$ 25.46MC$ 20.69M
Depreciation and Amortization
C$ 81.00KC$ 392.00KC$ 452.06KC$ 446.19KC$ 485.57K
EBITDA
C$ -33.71MC$ -26.83MC$ -25.80MC$ -25.37MC$ -20.02M
Operating Income
C$ -33.79MC$ -28.57MC$ -26.23MC$ -25.46MC$ -20.69M
Other Income/Expenses
C$ 6.14MC$ 2.17MC$ -20.05KC$ 2.95MC$ -12.43M
Pretax Income
C$ -27.66MC$ -24.75MC$ -26.25MC$ -22.51MC$ -33.12M
Net Income
C$ -27.75MC$ -24.84MC$ -26.30MC$ -19.55MC$ -45.55M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.41C$ -0.43C$ -0.49C$ -0.48C$ -2.06
Diluted EPS
C$ -0.41C$ -0.43C$ -0.49C$ -0.48C$ -2.06
Weighted Average Shares Outstanding
67.62M 58.03M 53.51M 40.34M 22.14M
Weighted Average Shares Outstanding (Diluted)
67.62M 58.03M 53.51M 40.34M 22.14M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis